It is with great enthusiasm that Renalida announces that its Director and founder, Dr. Paula Marioli, has been appointed as a member of the Clinical Trials Committee of the International Society of Nephrology (ISN). This prestigious appointment underscores Dr. Marioli’s track record of excellence and dedication to the field of nephrology.
The ISN is a globally recognized organization that leads efforts in nephrology research, education and clinical practice. The Clinical Trials Committee has the mission to guide and promote the conduct of high quality international clinical trials, essential to advance the prevention and treatment of kidney diseases.
Dr. Marioli’s participation in this committee represents not only a personal achievement, but also a recognition of the impact Renalida is having on the global renal health community. Her contributions will help improve the quality of life for millions of patients suffering from kidney disease around the world.
Renálida and its entire team congratulate Dr. Marioli on this important achievement and wish her every success in this new role.
Comité de Ensayos Clínicos de la ISN